Hong Kong stocks abnormal change | pharmaceutical stocks continue to rise, innovative drugs go overseas, domestic approval resonates. Institutions expect the industry's prosperity to continue throughout the year.

Wisdom Finance APP learned that pharmaceutical stocks continue to rise. As of the time of publication, Junshi Biosciences (01877.HK) rose by 5.53% to 20.05 Hong Kong dollars; CanSino Biologics-B (01877.HK) rose by 5.51% to 44.05 Hong Kong dollars; Hengrui Medicine (06127.HK) rose by 5.24% to 33.15 Hong Kong dollars; Rongchang Bioscience (09995) rose by 4.4% to 49.8 Hong Kong dollars.